Introduction
The total number of people living with the Human Immunodeficiency Virus (HIV) has reached its highest level and an estimated 40.3 million (36.7-45.3 million) people are now living with HIV. 1 Acquired Immunodeficiency Syndrome (AIDS) has killed more than 25 million people since it was first recognized in 1981, making it one of the most destructive epidemics in the recorded history. Despite recent improved access to antiretroviral treatment (ART) and care in many regions of the world, the AIDS epidemic claimed 3.1 million lives in 2005 of which more than half a million were children. 1 Transmission of HIV infection has been documented to occur through one or more of the four modes: sexual contact, exposure to blood-contaminated needles, administration of infected blood or blood products, and passage of virus from infected mother to their newborn babies. 2 As the prevalence of HIV infection increases, the general population will be at greater risk, primarily through heterosexual transmission. 3 The fear that HIV infection could be transmitted by blood transfusion, prompted the development of a diagnostic routine screening test for HIV antibodies. 4 In addition to ensuring safe blood transfusion, the test has been useful for other prevention efforts in high-risk groups and in making diagnosis of HIV infected patients. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] The EIA is the most widely used serological test for HIV antibody detection in the world today. Because EIA is very sensitive, very specific, fast and less expensive, it is used primarily as the screening test of choice. However, if a specimen is found repeatedly reactive with a screening test, it is re-tested with a supplemental assay such as WB, IFA or RIPA. Positive reactivity by one of these supplemental assays confirm the presence of HIV antibody. 15 Another very promising test is Line Immune Assay (LIA), the principle of which is similar to the WB. 16 Both the tests have several disadvantages namely high cost, variability in quality of strips, difficulty in defining minimum criteria for a positive result. 17 In contrast, IFA offers many practical advantages as a validating test for ELISA. The IFA is a routine test being familiar to trained clinical laboratory personnel. The test can be performed in less than 2 hours whereas LIA and WB require overnight incubation. The IFA is a less expensive method for HIV serology and can be used as screening as well as a confirmatory test. 7, 18, 19 Considering the above aspects of detection of HIV anitbody, the current study was designed to evaluate utility of the Indirect Immunofluorescence Assay (IFA) as a confirmatory test to detect HIV antibody.
Methods
This study was conducted in the department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka from July, 2005 to December, 2006. A total of 92 subjects were selected for the study of whom 46 were HIVantibody-positive patients and 46 were controls. The HIVantibody-positive patients were divided into two groups for the purpose of the study: Group I-consisting of 20 samples positive by screening tests (ELISA and Capillus), and Group II-comprising of 26 samples taken from preserved samples, which were kept at -20 o C in Virology laboratory of the BSMMU. The preserved samples were previously positive by ELISA and confirmed by western blot (WB) method. During the study, all 46 HIV-antibody-positive samples including groups I and II were tested by ELISA (re-tested for confirmation), LIA and IFA methods.
The controls comprised of different groups including healthy controls (n=16), patients with autoimmune disease like Systemic Lupus Erythematosus and Rheumatoid Arthritis (n=10), multiple blood-transfused patients like Thalassaemia and Leukaemia (n=10), and multipara pregnant women (n=10). The control groups were also tested by ELISA and IFA methods.
Enzyme Linked Immunosorbent Assay (ELISA)
By principle of the test, antibodies present in patient's serum react with antigens coated into microtiter plate. The antigens comprise of 3 recombinant (rec) proteins gp41, gp36 and p24 and peptide gp41. When antibodies against HIV-1 or HIV-2 were present in the test serum, the antibodies bound to the microplate. Any non-specifically bound material was removed by washing procedure and the antigen-conjugate was then added. The conjugate is a mixture of recombinant proteins and peptides from the Gag/Env regions of the HIV-1 and HIV-2 which are directly labelled with Horse Raddish Peroxidase. Unbound enzyme conjugate was removed in a further washing step. The presences of bound antibodyantigen complexes were demonstrated using enzyme reaction with Tetramethyl Benzidine (TMB) as a substrate, which resulted in a coloured product. The enzyme reaction was stopped using Sulphuric Acid and reading was taken by ELISA reader (Organo Teknika Microwell System, Germany) at 450 nm.
Indirect Immunofluorescence Assay (IFA)
For Indirect Immunofluorescence Assay (IFA) procedure, Fluorognost HIV-1 IFA kit (Sanochemia Inc., USA) was used. In the test procedure, HIV-infected and uninfected Tcells were applied to the well of fluorescence slide to make cell smears. Here, infected PALL T-cells and un-infected PALL T-cells were used in the glass slides of the kit to make cell smears. These cell smears were then air-dried, fixed in Acetone for 10 minutes and stored at -20 o C or below. During the assay, slides were warmed to room temperature, diluted test serum was applied to each well of the slide and incubated. 
Results
All samples (46) from the study subjects were found positive by repeat Enzyme Linked Immunosorbent Assay (ELISA). But 45 samples (19 from group I and 26 from group II) were positive by Indirect immunofluorescence Assay (IFA) and the remaining one sample from group I was negative by the test.
None of the control sera tested was positive for HIV antibody. (Table I) (Table I) Comparison between IFA and Line Immune Assay (LIA) on 34 HIV-antibody-positive sera showed that 33 were positive and 1 serum was negative by both the methods. So, the sensitivity and specificity of IFA was 100%. (Table II) For IFA method: calculated sensitivity = 100%, and specificity =100%
Discussion
This study was conducted to assess the appropriateness of Indirect Immunofluorescence Assay (IFA), which is less costly and takes less time. A study from India found the cost of testing by IFA 20% less than that of Western blot (WB) analysis. 17 However, IFA needs fluorescence microscope, which involves initial establishment, costing more than the WB or Line Immune Assay (LIA). But in laboratories where fluorescence microscope is already available, the IFA can be an inexpensive method of confirming the presence of HIV antibody.
In the present study, WB positive samples were tested by IFA for comparison. All 26 sera (group II) were also found positive by IFA method giving a 100% correlation between these two methods. There were excellent agreements in terms of sensitivity and specificity between IFA and WB in some previous studies. In a study, all 60 samples from 142 homosexual men were positive by Enzyme Immuno Assay (EIA), IFA and WB showing 100% agreement among them. 7 Another study from the USA demonstrated 100% agreement between IFA and WB on testing 271 sera from high risk group. 18 One study in Massachusetts General Hospital tested 104 sera by IFA and WB and found all 68 WB-negative sera also negative by IFA. One of the 36 WB-positive samples was found negative by IFA, and providing sensitivity and specificity of 97.22% (35/36) and 100% respectively. 9 Among 156 sera, investigated by Johnson et al (1988) , 18 were equivocal either by IFA or WB or both, allowing direct comparison of 138 specimens. Sensitivity of IFA compared to WB was 99.2% and specificity 100%. 20 Abraham et al (1994) in India demonstrated that among 42 WB-positive specimens, 41 were IFA positive, showing sensitivity of 97.6%. Of the 46 WB-negative samples, 45 were negative by IFA showing the specificity of 97.8%. 17 In the present study, LIA was done on 34 out of 46 HIVpositive samples due to reagent constraint. These samples were also tested by IFA. Comparison between these two test methods showed 100% correlation in terms of sensitivity and specificity. It was also observed that all the cases were positive for HIV-1 antibody, though antigens for both HIV-1 (gp120 and gp 41) and HIV-2 (gp 105 and gp 36) were fixed on the nitrocellulose strips. The present study indicated that none of the 33 HIV-positive samples tested by LIA was due to HIV-2 infection. All male subjects positive for HIV antibody in this study were migrant workers from the Middle East, Malaysia, Singapore and Thailand, where HIV-1 is prevalent. None of them was from Africa, where HIV-2 is present, probably because of this geographical distribution of the types, no HIV-2 was detected in this study.
In the present study, one sample positive for HIV antibody from "Group I," was found positive again when re-tested by ELISA. However, this sample was found negative when tested by IFA and LIA methods. This indicates that even the results obtained by the well-known 3-tests algorithm of highly sensitive and specific methods may sometimes show false positive results. So, all the positive sera found by the 3-tests algorithm should be confirmed by a supplementary test like LIA and IFA, especially in low-prevalent countries like Bangladesh.
In the present study, no false positive or non-specific result was seen by IFA method in HIV-antibody-positive patients as well as in control groups. Similarly, no false positive or nonspecific result was observed by IFA method in other studies. 19 Non-specific reaction may occur due to formation of anti-HLA antibodies, anti-nuclear antibody and anti-lymphocyte antibodies. 18, 20 In the present study, none of the control subjects showed any positive result with IFA. As such, it is suggested that WB and LIA can be replaced by IFA as a confirmatory test for HIV-antibody detection. However, further extensive studies should be done to achieve dependable conclusion.
